AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20859313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine and steroid (Group II)
Number of subjects: 120
Study 20859313 — intervention group
Group type: COMPARATOR
Intervention: Both groups (I and II)
Number of subjects: 120
Study 15642059 — intervention group
Group type: EXPERIMENTAL
Intervention: Test toothpaste containing 0.3% triclosan, 5% potassium nitrate, and 0.76% sodium monofluorophosphate (SMFP)
Number of subjects: 102
Study 15642059 — intervention group
Group type: COMPARATOR
Intervention: Control toothpaste containing 5% potassium nitrate and 0.76% SMFP
Number of subjects: 102
Study 15642059 — intervention group
Group type: EXPERIMENTAL
Intervention: Benchmark toothpaste containing only 0.76% SMFP
Number of subjects: 102
Study 12394804 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 600
Study 9987465 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite-plus-family intervention
Number of subjects: 1359
Study 9987465 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite intervention
Number of subjects: 1359
Study 9987465 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention control group
Number of subjects: 1359
Study 9987465 — intervention group
Group type: COMPARATOR
Intervention: Comparison of worksite-plus-family group to control group
Number of subjects: 1359
Study 7484858 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dofetilide at doses of 3.0 to 15.0 micrograms/kg
Number of subjects: 50
Study 7484858 — intervention group
Group type: COMPARATOR
Intervention: Intravenous dofetilide at a dose of 1.5 micrograms/kg
Number of subjects: 50
Study 2310104 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtracheal oxygen delivery
Number of subjects: 11
Study 2310104 — intervention group
Group type: COMPARATOR
Intervention: Nasal cannula oxygen delivery
Number of subjects: 11
Study 7022420 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin 1 mg
Number of subjects: 0
Study 7022420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31916229 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic inflammation (measured by serum CRP)
Number of subjects: 220
Study 31916229 — intervention group
Group type: EXPERIMENTAL
Intervention: LAVI (left atrial volume indexed to body surface area)
Number of subjects: 220
Study 31916229 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal analysis using Mixed Linear Model
Number of subjects: 220
Study 29987587 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral botulinum toxin (BT) therapy using CBTX‐A, standard doses on affected side, one-third doses on non-affected side
Number of subjects: 43
Study 29987587 — intervention group
Group type: COMPARATOR
Intervention: Unilateral botulinum toxin (BT) therapy
Number of subjects: 43
Study 29987587 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral botulinum toxin (BT) therapy
Number of subjects: 43
Study 29444394 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (group S)
Number of subjects: 50
Study 29444394 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (group G)
Number of subjects: 50
Study 25200354 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2b 1.5μg/kg/wk for 48 weeks (arm C)
Number of subjects: 670
Study 25200354 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN alfa‐2b 1.0μg/kg/wk for 24 weeks (arm A)
Number of subjects: 670
Study 25200354 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN alfa‐2b 1.5μg/kg/wk for 24 weeks (arm B)
Number of subjects: 670
Study 22733398 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptorelin pamoate (TP) at a dose of 11.5 mg at 3-month intervals until documented progression
Number of subjects: 36
Study 22733398 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptorelin pamoate (TP)
Number of subjects: 36
Study 20496365 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran 100 mg/day
Number of subjects: 1025
Study 20496365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1025
Study 18389076 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide
Number of subjects: 0
Study 18389076 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 16279146 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 0
Study 16279146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12496050 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (15 weeks of supervised training followed by 6 months of unsupervised training)
Number of subjects: 54
Study 12496050 — intervention group
Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 54
Study 10515676 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 50 mg twice weekly associated with cyclic medroxyprogesterone acetate 10 mg daily (n = 10)
Number of subjects: 21
Study 10515676 — intervention group
Group type: COMPARATOR
Intervention: Tibolone 2.5 mg administered orally once a day (n = 11)
Number of subjects: 21
Study 7669823 — intervention group
Group type: EXPERIMENTAL
Intervention: Attacks by mentally ill individuals
Number of subjects: 0
Study 7669823 — intervention group
Group type: COMPARATOR
Intervention: Post-attack social attitudes
Number of subjects: 0
Study 7669823 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional replication of public attitude change
Number of subjects: 0
Study 2341686 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary sheath system with a specific leg-bag design
Number of subjects: 30
Study 2341686 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid urinary sheath system
Number of subjects: 30
Study 2341686 — intervention group
Group type: COMPARATOR
Intervention: Alternative urinary sheath systems
Number of subjects: 30
Study 7451921 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe esophagitis
Number of subjects: 0
Study 7451921 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up motility studies 1 month after injury
Number of subjects: 0
Study 7451921 — intervention group
Group type: COMPARATOR
Intervention: Mild caustic esophagitis
Number of subjects: 0
Study 31262319 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical flow perturbation training (10 min treadmill walking with optical flow perturbations)
Number of subjects: 13
Study 31262319 — intervention group
Group type: COMPARATOR
Intervention: Control session (10 min treadmill walking without optical flow perturbations)
Number of subjects: 13
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist Circumference (WC)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist to Hip Ratio (WHR)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist to Height Ratio (WHtR)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI for metabolic syndrome markers (females)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: WC for metabolic syndrome markers (females)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: WHtR for metabolic syndrome markers (females)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: WHR for metabolic syndrome markers (females)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI for metabolic syndrome markers (males)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: WC for metabolic syndrome markers (males)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: WHtR for metabolic syndrome markers (males)
Number of subjects: 704
Study 30466421 — intervention group
Group type: EXPERIMENTAL
Intervention: WHR for metabolic syndrome markers (males)
Number of subjects: 704
Study 27157033 — intervention group
Group type: EXPERIMENTAL
Intervention: Concrete processing mode
Number of subjects: 50
Study 27157033 — intervention group
Group type: COMPARATOR
Intervention: Abstract processing mode
Number of subjects: 50
Study 24744082 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) intervention with inpatient introductory visit and weekly post‐discharge telephonic support for 4 weeks
Number of subjects: 423
Study 24744082 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 423
Study 22511036 — intervention group
Group type: EXPERIMENTAL
Intervention: 595 nM pulsed-dye laser (PDL) at pulse energy of 15 J/cm², 3-millisecond pulse length, 7-mm spot size, 10% overlap of pulses, two passes
Number of subjects: 20
Study 22511036 — intervention group
Group type: EXPERIMENTAL
Intervention: 595 nM pulsed-dye laser (PDL) at pulse energy of 7.5 J/cm², 3-millisecond pulse length, 10-mm spot size, 10% overlap of pulses, double stacked pulses
Number of subjects: 20
Study 22511036 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study 20447629 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical subinguinal varicocelectomy (MSSIV)
Number of subjects: 162
Study 20447629 — intervention group
Group type: COMPARATOR
Intervention: Conventional, nonmagnified subinguinal varicocelectomy (NMSIV)
Number of subjects: 162
Study 17964875 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous peripheral nerve stimulation (PNS)
Number of subjects: 9
Study 17964875 — intervention group
Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 9
Study 17964875 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous PNS
Number of subjects: 9
Study 16126049 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 50
Study 16126049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11392579 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 0
Study 11392579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9701421 — intervention group
Group type: EXPERIMENTAL
Intervention: levodropropizine (75 mg t.i.d.; 7 days)
Number of subjects: 140
Study 9701421 — intervention group
Group type: COMPARATOR
Intervention: dihydrocodeine (10 mg t.i.d.; 7 days)
Number of subjects: 140
Study 7913452 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention involving visits by a GP or pharmacist trained in communication skills, providing relaxation tapes and management guidelines.
Number of subjects: 137
Study 7913452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rating of benzodiazepine prescribing by GPs.
Number of subjects: 137
Study 2638619 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk substitute with taurine
Number of subjects: 20
Study 2638619 — intervention group
Group type: COMPARATOR
Intervention: Breast milk substitute without taurine
Number of subjects: 20
Study 31842860 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianshu capsule (TSC) 4.08 g, three times daily
Number of subjects: 1000
Study 31842860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 27370816 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate
Number of subjects: 122
Study 27370816 — intervention group
Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 122
Study 26044701 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial injection of autologous bone marrow mononuclear cells (2×10^6/kg or 5×10^6/kg)
Number of subjects: 76
Study 26044701 — intervention group
Group type: COMPARATOR
Intervention: Non-treated group
Number of subjects: 76
Study 23808439 — intervention group
Group type: EXPERIMENTAL
Intervention: EG2 (4 PE sessions/week of high intensity)
Number of subjects: 67
Study 23808439 — intervention group
Group type: COMPARATOR
Intervention: CG (usual PE in Spain, 2 sessions/week)
Number of subjects: 67
Study 21653833 — intervention group
Group type: EXPERIMENTAL
Intervention: MOG(97‐109)‐reactive CD4(+) T cells isolated with DRB1*0401/MOG(97‐109) tetramers after culture with MOG(97‐109) peptides
Number of subjects: 0
Study 21653833 — intervention group
Group type: EXPERIMENTAL
Intervention: T cell clones from single cell cloning of DRB1*0401/MOG(97‐109(107E‐S)) tetramer(+) cells
Number of subjects: 0
Study 21653833 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II tetramers used for detection
Number of subjects: 0
Study 21653833 — intervention group
Group type: COMPARATOR
Intervention: MOG(97‐109)‐reactive T cells
Number of subjects: 0
Study 19543851 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (etoposide and vincristine, combined with either carboplatin or cyclophosphamide)
Number of subjects: 30
Study 19543851 — intervention group
Group type: COMPARATOR
Intervention: Observation (no chemotherapy)
Number of subjects: 30
Study 19543851 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (chemotherapy)
Number of subjects: 30
Study 19543851 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical outcomes
Number of subjects: 30
Study 16423676 — intervention group
Group type: EXPERIMENTAL
Intervention: Left bundle branch block (LBBB)
Number of subjects: 94
Study 14996778 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurolytic celiac plexus block (NCPB)
Number of subjects: 100
Study 14996778 — intervention group
Group type: COMPARATOR
Intervention: Opioids alone (systemic analgesic therapy with a sham injection)
Number of subjects: 100
Study 11737373 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC + CART
Number of subjects: 185
Study 11737373 — intervention group
Group type: COMPARATOR
Intervention: CART
Number of subjects: 185
Study 9506654 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg phenobarbital intravenously over 1 hour
Number of subjects: 31
Study 9506654 — intervention group
Group type: COMPARATOR
Intervention: Control group (no phenobarbital)
Number of subjects: 31
Study 7802250 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 100
Study 7802250 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 100
Study 2902779 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine in patients with mixed angina
Number of subjects: 72
Study 2902779 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine in patients with classic exertional angina
Number of subjects: 72
Study 2902779 — intervention group
Group type: COMPARATOR
Intervention: Placebo in patients with mixed angina
Number of subjects: 72
Study 2902779 — intervention group
Group type: COMPARATOR
Intervention: Placebo in patients with classic exertional angina
Number of subjects: 72
Study 31963163 — intervention group
Group type: EXPERIMENTAL
Intervention: NALC
Number of subjects: 12
Study 31963163 — intervention group
Group type: EXPERIMENTAL
Intervention: ALC
Number of subjects: 12
Study 31362557 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate MRI of the wrist during the initial ED attendance
Number of subjects: 132
Study 31362557 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further imaging)
Number of subjects: 132
Study 31362557 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate MRI of the wrist
Number of subjects: 132
Study 28824296 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 12
Study 28824296 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin
Number of subjects: 12
Study 25478956 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention (Bounce Back Now)
Number of subjects: 0
Study 25478956 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 24348624 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation applied for 30 seconds on one half of the maxillary and mandibular arches for 5 days.
Number of subjects: 29
Study 24348624 — intervention group
Group type: COMPARATOR
Intervention: Control group (opposite half of the arches without laser irradiation).
Number of subjects: 29
Study 24348624 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation.
Number of subjects: 29
Study 21998656 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor skill learning intervention
Number of subjects: 6
Study 21998656 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 6
Study 18438240 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 sets of stretches (90 seconds per muscle group)
Number of subjects: 20
Study 16931218 — intervention group
Group type: EXPERIMENTAL
Intervention: Once every 2 weeks subcutaneous epoetin beta (group 2w)
Number of subjects: 207
Study 16931218 — intervention group
Group type: EXPERIMENTAL
Intervention: Once weekly subcutaneous epoetin beta (group 1w)
Number of subjects: 207
Study 12297476 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine on the basis of conventional therapy lasting till 30 days after injuries
Number of subjects: 80
Study 12297476 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy including craniotomy, hemostasis, dehydration, anti-infection and corticosteroid administration
Number of subjects: 80
Study 14528541 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthritis presence
Number of subjects: 0
Study 8672322 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam-clonidine
Number of subjects: 197
Study 8672322 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormethiazole-haloperidol
Number of subjects: 197
Study 8672322 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam-haloperidol
Number of subjects: 197
Study 8672322 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 197
Study 2263264 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of dimethylfumarate and different salts of monoethylfumarate
Number of subjects: 39
Study 2263264 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 39
Study 2263264 — intervention group
Group type: COMPARATOR
Intervention: Octylhydrogen fumarate
Number of subjects: 39
Study 512148 — intervention group
Group type: EXPERIMENTAL
Intervention: VMIP depression
Number of subjects: 60
Study 512148 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic suggestion
Number of subjects: 60
Study 512148 — intervention group
Group type: COMPARATOR
Intervention: VMIP neutral
Number of subjects: 60
Study 512148 — intervention group
Group type: COMPARATOR
Intervention: Self-devaluation
Number of subjects: 60
Study 512148 — intervention group
Group type: COMPARATOR
Intervention: VMIP elation
Number of subjects: 60
Study 6602783 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepridil (2 mg/kg, intravenous infusion)
Number of subjects: 12
Study 6602783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30672251 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoshen Acupuncture
Number of subjects: 98
Study 30672251 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture (Control)
Number of subjects: 98
Study 29107495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral TXA (2 g orally 2 hours preoperatively)
Number of subjects: 180
Study 29107495 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TXA (20 mg/kg intravenous bolus 5 minutes before incision)
Number of subjects: 180
Study 29107495 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA (2 g applied topically)
Number of subjects: 180
Study 29107495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral TXA
Number of subjects: 180
Study 29107495 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TXA
Number of subjects: 180
Study 29107495 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA
Number of subjects: 180
Study 29107495 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 180
Study 27480965 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID Before Food (BF)
Number of subjects: 160
Study 27480965 — intervention group
Group type: COMPARATOR
Intervention: NSAID After Food (AF)
Number of subjects: 160
Study 27480965 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID BF for 2 days then AF for next two days (CO-1)
Number of subjects: 160
Study 27480965 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID AF for 2 days then BF for next two days (CO-2)
Number of subjects: 160
Study 24608161 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (Goserelin)
Number of subjects: 30
Study 24608161 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist + GnRH antagonist (Goserelin and Cetrorelix)
Number of subjects: 30
Study 24608161 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 30
Study 22568450 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress coping capacity with spinal anaesthesia
Number of subjects: 162
Study 22568450 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stress coping capacity with spinal anaesthesia
Number of subjects: 162
Study 22568450 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 162
Study 22568450 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 162
Study 20837645 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted exercise training (F; n = 10)
Number of subjects: 27
Study 20837645 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-fed exercise training (CHO; n = 10)
Number of subjects: 27
Study 20837645 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON; n = 7)
Number of subjects: 27
Study 17664499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)‐type intervention plus a consultation letter
Number of subjects: 0
Study 17664499 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care plus a consultation letter
Number of subjects: 0
Study 17664499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)‐type intervention
Number of subjects: 0
Study 16224161 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPD patients
Number of subjects: 25
Study 16224161 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPD patients with carotid artery calcified plaques
Number of subjects: 25
Study 16224161 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 25
Study 12105840 — intervention group
Group type: EXPERIMENTAL
Intervention: rFVIIa (4 doses: 5, 20, 80, and 120 microg/kg)
Number of subjects: 71